Genmab — Maj 2018
-
Børsens teknikere er på sagen nu.
-
200 er vist et flot antal i safety.
-
To sjæle - en tanke.
-
This Tisotumab Vedotin trial was already completed in december, i think i missed that
https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-001120-29/DK#P -
this is the open TV just to be complete https://www.clinicaltrialsregister.eu/ctr-search/trial/2016-004743-37/BE
-
coincidence?: Roche’s Tecentriq scores again on a pivotal frontline lung cancer trial, … https://endpts.com/roches-tecentriq-scores-again-on-a-pivotal-frontline-lung-cancer-trial-positioning-them-against-merck-bristol-myers/
-
Barclays https://twitter.com/search?f=tweets&vertical=default&q=genmab OR daratumumab OR darzalex OR ofatumumab&src=savs
"We had been valuing the solid tumours as 4% of NPV" and then they say "the removel of solid tumours does result in a 13% reduction to NPV"???
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind